Ophthalmic Drug Delivery Systems
2nd Edition
Published on 25. March 2003
847 pages
978-1-135-54321-1 (ISBN)
Description
The second edition of this text assembles significant ophthalmic advances and encompasses breakthroughs in gene therapy, ocular microdialysis, vitreous drug disposition modelling, and receptor/transporter targeted drug delivery.
More details
Edition
2nd edition
Language
English
Place of publication
London
United Kingdom
Publishing group
Taylor & Francis Ltd
Target group
Professional and scholarly
Edition type
Revised edition
Product notice
Reflowable
ISBN-13
978-1-135-54321-1 (9781135543211)
Copyright in bibliographic data and cover images is held by Nielsen Book Services Limited or by the publishers or by their respective licensors: all rights reserved.
Schweitzer Classification
Other editions
Additional editions
Ashim K. Mitra
Ophthalmic Drug Delivery Systems
Book
12/2019
2nd Edition
CRC Press
€98.90
Shipment within 15-20 days
Book
06/2014
2nd Edition
Marcel Dekker Inc
€161.21
Shipment within 15-20 days
Ashim K. Mitra
Ophthalmic Drug Delivery Systems
Book
03/2003
2nd Edition
CRC Press
€272.81
Shipment within 15-20 days
Content
I: Fundamental Considerations 1. Overview of Ocular Drug Delivery 2. Membrane Transport Processes in the Eye 3. General Considerations in Ocular Drug Delivery II: Transport Models in Ocular Drug Delivery 4. Ocular Drug Transfer following Systemic Drug Administration 5. Ocular Pharmacokinetics and Pharmacodynamics 6. Mathematical Modeling of Drug Distribution in the Vitreous Humor 7. Anterior Segment Microdialysis 8. Posterior Segment Microdialysis III: Drug Delivery Systems 9. Ocular Penetration Enhancers 10. Corneal Collagen Shields for Ocular Drug Delivery 11. The Noncorneal Route in Ocular Drug Delivery 12. Ocular Iontophoresis 13. Mucoadhesive Polymers in Ophthalmic Drug Delivery 14. Microparticles and Nanoparticles in Ocular Drug Delivery 15. Dendrimers: An Innovative and Enhanced Ocular Drug Delivery System 16. Ocular Delivery and Therapeutics of Proteins and Peptides 17. Retinal Disease Models for Development of Drug and Gene Therapies 18. New Experimental Therapeutic Approaches for Degenerative Diseases of the Retina 19. Gene, Oligonucleotide, and Ribozyme Therapy in the Eye IV: Regulatory Aspects 20. Regulatory Considerations 21. Patent Considerations
